Acusphere, Inc. - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Acusphere, Inc. Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Acusphere, Inc.. The Group's principal activity is to develop new drugs and improved formulations of existing drugs using proprietary porous microparticle technology. It focused on developing proprietary drugs, including improved safety and efficacy, increased patient compliance, greater ease of use, expanded indications or reduced cost. It develops proprietary drug that offers benefits such as improved safety and efficacy, increased patient compliance and greater ease of use. Its products are in clinical development and are designed to address clinical needs within cardiology, oncology and asthma. It has initially applied its technology in its research and development efforts in areas of AI-700, Intravenous Delivery of Gas for Ultrasound Contrast; AI-850, first clinical-stage product candidate from its Hydrophobic Drug Delivery System, and AI-128, first clinical-stage product candidate from its Pulmonary Drug Delivery System. The Group is a development stage company.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report